<DOC>
	<DOCNO>NCT02347943</DOCNO>
	<brief_summary>This study evaluate long-term safety effectiveness primary sinus surgery real-world population adult chronic rhinosinusitis ( CRS ) recurrent acute rhinosinusitis ( RARS ) . This post-market study evaluate sinus surgery perform use commercially available sinus instrumentation ( e.g . sinus balloon catheter , power microdebriders , manual instrument ) .</brief_summary>
	<brief_title>Global Sinus Surgery Registry</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<criteria>Age â‰¥ 18 year minimum adult age require local regulation The subject plan primary sinus surgery , include either traditional transnasal endoscopic sinus surgery ( ESS ) , balloon sinus dilation ( BSD ) hybrid procedure Subjects diagnose ENT surgeon chronic rhinosinusitis ( CRS ) recurrent acute rhinosinusitis ( RARS ) per AAOHNS EPOS adult sinusitis clinical practice guideline The subject informed nature registry consent participate authorize collection release medical information sign consent form Subject able read understand local language Prior sinus surgery . Septoplasty , Nasal Polypectomy , Septorhinoplasty , Nasal Valve Turbinate Reduction surgery exclusion Planned surgery following : orbital decompression , skull base , neoplasm , lacrimal , UPPP , aesthetic surgery , Potts Puffy tumor , Draf III Planned external approach ( i.e . transnasal ) Planned offlabel usage balloon sinus dilation product . Balloon sinus dilation perform nonAcclarent balloon product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>